top of page

ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V

Product details

Registration number: SIN15261P

Classification: Prescription Only

Active ingredients: Ropivacaine base 8.826 mg/mL eqv Ropivacaine hydrochloride

Strength: 10 mg/mL

Dosage form: INJECTION, SOLUTION

Route: EPIDURAL

Registrant: APEX PHARMA MARKETING PTE. LTD.

ATC code: N01BB09

HSA approval date: 8 June 2017

Manufacturer(s): Elpen Pharmaceutical Co., Inc

Manufacturing country/countries: GREECE

What are the HSA registration number and classification for ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15261P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Ropivacaine base 8.826 mg/mL eqv Ropivacaine hydrochloride

Strength: 10 mg/mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: EPIDURAL

Source for this answer

Who is the recorded registrant for ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V?

According to the HSA dataset updated 7 August 2026:

Registrant: APEX PHARMA MARKETING PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Elpen Pharmaceutical Co., Inc

Manufacturing country/countries: GREECE

Source for this answer

Where can I look up ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15261P or the exact product name ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ROPIVACAINE-AFT SOLUTION FOR INJECTION 1% W/V record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15261P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page